Socialising securely this winter October 29, 2021 | Sponsored Life has begun to return to what feels like normal after so many months of the pandemic stopping us doing the things we love. But as we look forward to Christmas, it’s important we remember that the virus is still with us – and we still need to take sensible precautions to make sure we [...]
How’s vaccine inequality driving up global inflation? October 27, 2021 | City Talk As the more highly vaccinated countries roll out Covid booster shots, other parts of the world are still struggling to get their first jab. The vaccine divide is more apparent in the emerging markets (EM). World organisations have voiced their concerns over “vaccine nationalism” whereby vaccine-exporting countries prioritise supply first for their own populations before [...]
Winter is coming – but we have the vaccines to keep us going October 26, 2021 | Sponsored It’s been impossible not to notice the temperatures falling and the winter nights slowly drawing in. Whilst we can look forward to cosy Autumnal nights and frosty winter walks, that change in the weather also means it’s time to redouble our efforts to fight not just Covid-19, but flu, too. Due to last year’s winter [...]
Covid-19 booster vaccinations: All your questions answered October 26, 2021 A third Covid shot is coming your way this winter as two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England and Morning Wire caught up with Phil Day, superintendent pharmacist at Pharmacy2U, to discuss [...]
GSK waves goodbye to West London as breakup begins with new £120m HQ October 11, 2021 GlaxoSmithKline will move its global headquarters to a new £120m site, as the pharmaceutical giant prepares to split up its empire into two separate businesses. The company today announced plans for a shiny new £120m headquarters in Weybridge for its new independent consumer healthcare company. Remaining pharmaceuticals and vaccine staff will also relocate from the [...]
Covid protection from Pfizer vaccine drops to 47 per cent six months after second dose October 5, 2021 The effectiveness of the Pfizer/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47 per cent from 88 per cent six months after the second dose, according to data published that U.S. health agencies considered when deciding on the need for booster shots. Watch the full report.
New Covid vaccine formulation could be needed by mid-2022, says BioNTech boss October 4, 2021 The boss of BioNTech, the German biotech firm behind the Pfizer Covid-19, has predicted that a new formulation for jabs will likely be needed by mid-2022. Scientists have warned that the virus could mutate in a way that means it is less resistant to vaccines. “This year [a different vaccine] is completely unneeded. But by [...]
Your third Covid shot is coming: All you need to know about booster vaccines October 3, 2021 It seems inevitable: a third Covid shot is coming your way this Autumn. Two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England. Some 1.5 million people will be contacted and encouraged to use the [...]
New Covid-19 pill in Germany exceeds all expectations as it reduces Coronavirus deaths by half October 3, 2021 A new experimental Covid-19 pill reduced stays in hospital and deaths by half, according to German multinational science and technology company Merck. In fact, an independent group of medical experts that monitored the trial recommended stopping it early because the interim results were so strong, beating all expectations. The company said today it would soon [...]
Pfizer and Moderna down: Merck’s stock skyrockets after its new Covid antiviral pill smashes all expectations October 1, 2021 Shares in US science giant Merck are up by more than 10 per cent this afternoon after the company revealed a newly developed Covid-19 pill smashes all expectations. As a result, vaccine giants across the board are down, Pfizer by nearly 2 per cent, Moderna 4.7 per cent and Novavax dropped by 7.5%. The companies [...]